4th International Consensus Conference: Primary Systemic Treatment in the Management of Operable Breast Cancer: Toward the Rapid Assessment of Therapy EfficacyBOTTINI, Alberto; BERRUTI, Alfredo; GENERALI, Daniele et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, issn 1052-6773, 101 p.Conference Proceedings

Overcoming breast cancer drug resistance with mTOR inhibitors. Could it be a myth or a real possibility in the short-term future?MARGARITI, Nadia; FOX, Stephen B; BOTTINI, Alberto et al.Breast cancer research and treatment. 2011, Vol 128, Num 3, pp 599-606, issn 0167-6806, 8 p.Article

Mechanisms of Resistance to HER2 Target TherapyTORTORA, Giampaolo.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 95-98, issn 1052-6773, 4 p.Conference Paper

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective studyCAMPIGLIO, Manuela; BUFALINO, Rosaria; BOTTINI, Alberto et al.Breast cancer research and treatment. 2011, Vol 128, Num 1, pp 147-154, issn 0167-6806, 8 p.Article

Intermediate Endpoints of Primary Systemic Therapy in Breast Cancer PatientsBERRUTI, Alfredo; GENERALI, Daniele; BERTAGLIA, Valentina et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 142-146, issn 1052-6773, 5 p.Conference Paper

Synergistic activity of letrozole and sorafenib on breast cancer cellsBONELLI, Mara A; FUMAROLA, Claudia; EVANS, Dean B et al.Breast cancer research and treatment. 2010, Vol 124, Num 1, pp 79-88, issn 0167-6806, 10 p.Article

Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancerGENERALI, Daniele; FOX, Stephen B; CAMPO, Leticia et al.Clinical cancer research. 2007, Vol 13, Num 2, pp 550-558, issn 1078-0432, 9 p., 1Article

Assessing Early Therapeutic Response to Bevacizumab in Primary Breast Cancer Using Magnetic Resonance Imaging and Gene Expression ProfilesMEHTA, Shaveta; HUGHES, Nicholas P; HARRIS, Adrian L et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 71-74, issn 1052-6773, 4 p.Conference Paper

The Pathologic Complete Response Open Question in Primary TherapyMARCHIO, Caterina; SAPINO, Anna.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 86-90, issn 1052-6773, 5 p.Conference Paper

The Triple-Negative Subtype: New Ideas for the Poorest Prognosis Breast CancerCURIGLIANO, Giuseppe; GOLDHIRSCH, Aron.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 108-110, issn 1052-6773, 3 p.Conference Paper

The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with BortezomibMILANI, Manuela; RZYMSKI, Tomasz; MELLOR, Howard R et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 10, pp 4415-4423, issn 0008-5472, 9 p.Article

Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patientsBOTTINI, Alberto; GENERALI, Daniele; DIONISIO, Rossana et al.Journal of clinical oncology. 2006, Vol 24, Num 22, pp 3623-3628, issn 0732-183X, 6 p.Article

Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patientsBERRUTI, Alfredo; BITOSSI, Raffaella; FARRIS, Antonio et al.European journal of cancer (1990). 2005, Vol 41, Num 2, pp 249-255, issn 0959-8049, 7 p.Article

Double-Blind, Placebo-Controlled, Multicenter, Randomized, Phase IIB Neoadjuvant Study of Letrozole-Lapatinib in Postmenopausal Hormone Receptor―Positive, Human Epidermal Growth Factor Receptor 2-Negative, Operable Breast CancerGUARNERI, Valentina; GENERALI, Daniele Giulio; BISAGNI, Giancarlo et al.Journal of clinical oncology. 2014, Vol 32, Num 10, pp 1050-1057, issn 0732-183X, 8 p.Article

Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Blood Oxygenation Level-Dependent Magnetic Resonance Imaging for the Assessment of Changes in Tumor Biology With TreatmentLI, Sonia P; PADHANI, Anwar R; MAKRIS, Andreas et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 103-107, issn 1052-6773, 5 p.Conference Paper

Endocrine Therapy, New Biologicals, and New Study Designs for Presurgical Studies in Breast CancerDOWSETT, Mitch; SMITH, Ian; SKENE, Tony et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 120-123, issn 1052-6773, 4 p.Conference Paper

Positron Emission Tomography and Neoadjuvant Therapy of Breast CancerCOCHET, Alexandre; GENERALI, Daniele; FOX, Stephen B et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 111-115, issn 1052-6773, 5 p.Conference Paper

Surrogate Markers for Targeted Therapy―Based Treatment Activity and EfficacyBIANCHINI, Giampaolo; GIANNI, Luca.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 91-94, issn 1052-6773, 4 p.Conference Paper

The Value of Genomic Analysis of Breast Cancer in Drug DevelopmentSZEKELY, Borbala; PUSZTAI, Lajos.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 60-62, issn 1052-6773, 3 p.Conference Paper

Phase II, randomized trial of preoperative epirubicin-paclitaxel +/-gefitinib with biomarker evaluation in operable breast cancerGUARNERI, Valentina; FRASSOLDATI, Antonio; BATTELLI, Nicola et al.Breast cancer research and treatment. 2008, Vol 110, Num 1, pp 127-134, issn 0167-6806, 8 p.Article

Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2―Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB StudyGUARNERI, Valentina; FRASSOLDATI, Antonio; UNTCH, Michael et al.Journal of clinical oncology. 2012, Vol 30, Num 16, pp 1989-1995, issn 0732-183X, 7 p.Article

Bridging the Gap Between Translational Research and Clinical ApplicationMILLER, William R; LARIONOV, Alexey A.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 134-137, issn 1052-6773, 4 p.Conference Paper

The HER2 World: Better Treatment Selection for Better OutcomeTAGLIABUE, Elda; CAMPIGLIO, Manuela; PUPA, Serenella M et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 82-85, issn 1052-6773, 4 p.Conference Paper

Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patientsMELE, Teresa; GENERALI, Daniele; DOGLIOTTI, Luigi et al.Breast cancer research and treatment. 2010, Vol 123, Num 3, pp 795-804, issn 0167-6806, 10 p.Article

Immunomodulation of FOXP3⁺ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer PatientsGENERALI, Daniele; BATES, Gaynor; DOGLIOTTI, Luigi et al.Clinical cancer research (Print). 2009, Vol 15, Num 3, pp 1046-1051, issn 1078-0432, 6 p.Article